
Publication|Articles|October 10, 2025
- October 2025
- Volume 91
- Issue 10
FDA Approvals for September 2025
Author(s)PT Staff
Key Takeaways
- Recent FDA approvals highlight advancements in oncology, focusing on therapies targeting specific genetic mutations for personalized treatment.
- Expedited review processes by the FDA have enabled quicker access to innovative cancer treatments, improving patient outcomes.
Explore recent FDA-approved drugs from September 2025.
Advertisement
FDA Approvals
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
2
New Report Details Rising Incidence of Invasive Lobular Carcinoma
3
Breaking News: AstraZeneca, White House Announce Most-Favored-Nation Deal
4
The 3 Skills You Will Need Most
5